Escherichia coli

Escherichia coli is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --


  • Aerobic, gram-negative (GN) rod, E. coli is a member of Enterobacteriaceae: human strains may be: (1) commensal bowel flora, (2) intestinal pathogenic (enteric/diarrheogenic), (3) extra-intestinal pathogenic.
    • Predominant GN in composition of normal human colonic flora.
    • Motile, flagellated, non-spore forming.
  • E. coli easy to grow from sterile specimens.
    • Stool cx: only if severe diarrhea (may need reference lab to ID) or suspect O157:H7 (cx all bloody diarrhea) use sorbitol-MacConkey agar or perform Shiga toxin EIA.
    • ~ 90% strains ferment lactose (i.e., lactose-fermenter, D-glucose fermentation produces mixed acids that trigger an indicator such as methyl red)
      • Some diarrheogenic E. coli strains, including many of the EIEC strains, typically lactose negative.
      • Indole testing in all E. coli ~ 99% (+).
      • Catalase positive, oxidase negative.
  • Major resistance concerns[14]:
    • Plasmid-mediated AmpC β-lactamases (e.g., CMY)
    • Extended-spectrum β-lactamases (e.g., CTX-M)
      • Now worldwide concern in community-acquired UTIs and also bloodstream infections
      • In some Asian countries rates of ESBL E. coli have been reported as high as 55-79%.
      • Rates are lower in North America but rising.
    • Carbapenemases (e.g., New Delhi metallo-β-lactamase, Klebsiella pneumonaie carbapenemase and OXA-48)

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: February 8, 2018